Ramy Farid - 03 Mar 2025 Form 4 Insider Report for Schrodinger, Inc. (SDGR)

Role
President & CEO, Director
Signature
/s/ Donald Shum, as attorney-in-fact for Ramy Farid
Issuer symbol
SDGR
Transactions as of
03 Mar 2025
Net transactions value
$0
Form type
4
Filing time
04 Mar 2025, 17:28:42 UTC
Previous filing
31 May 2024
Next filing
02 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SDGR Common Stock Award $0 +37,500 +20% $0.000000 221,932 03 Mar 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SDGR Stock Option (right to buy) Award $0 +60,000 $0.000000 60,000 03 Mar 2025 Common Stock 60,000 $21.24 Direct F3
transaction SDGR Stock Option (right to buy) Award $0 +90,000 $0.000000 90,000 03 Mar 2025 Common Stock 90,000 $23.36 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on March 3, 2025 and will vest in equal installments on each of March 4, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continued service with the company.
F2 Includes 37,500 unvested RSUs.
F3 The option was granted on March 3, 2025. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 3, 2026 and the remainder are scheduled to vest in equal monthly installments through March 3, 2029.
F4 The option was granted on March 3, 2025. The exercise price per share is equal to 110% of the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 3, 2026 and the remainder are scheduled to vest in equal monthly installments through March 3, 2029.